Document Detail

Everolimus-Eluting Stents Versus Sirolimus- or Paclitaxel-Eluting Stents: Two-Year Results from the Guthrie Health Off-Label Stent (GHOST) Registry.
MedLine Citation:
PMID:  23363439     Owner:  NLM     Status:  Publisher    
OBJECTIVES: We sought to compare the safety and effectiveness of everolimus-eluting stents (EES) versus first generation drug-eluting stents (FG-DES; sirolimus-eluting stent [SES] or paclitaxel-eluting stent [PES]). METHODS: In 2,126 patients undergoing percutaneous coronary intervention (PCI), we compared the 2-year incidence of stent thrombosis (ST) and target vessel revascularization (TVR) between the EES versus FG-DES groups. Secondary end-points included all-cause death, myocardial infarction (MI), death or MI, and major adverse cardiovascular events (MACE, including death, MI, ST, or TVR). Further, we evaluated these end-points in 2 propensity-matched subgroups: EES versus SES; EES versus PES. RESULTS: Complete 2-year follow-up was available in 1,911 (90%) patients. Compared to FG-DES, implantation of EES was associated with trends towards lower ST (0.9% vs. 2.8%, P = 0.068) and TVR (3.8% vs. 7.2%, P = 0.052), which persisted after adjustment for baseline differences (for ST, adjusted hazard ratio, HR 0.32; 95% confidence interval, 95% CI 0.10-1.02, P = 0.053; for TVR, HR 0.40; 95% CI 0.22-0.75, P = 0.004). Compared to SES, EES implantation was associated with lower TVR and a trend towards lower ST. Compared to PES, EES implantation was associated with less ST and TVR and trends towards lower death/MI and MACE. In the EES group, no ST was seen after the first 3 months. CONCLUSIONS: The use of EES compared to FG-DES appears to be associated with reductions in ST and TVR at 2-year follow-up. Improved outcomes with EES are observed in comparison with SES as well as PES.
Kishore J Harjai; Sreekanth Kondareddy; Brian Pinkosky; Neil Harjai; Pam Orshaw; Judy Boura
Related Documents :
21109259 - Tacrolimus attenuates myocardium damage to the total hepatic ischemia-reperfusion via r...
21345779 - Levitronix centrimag pump as perioperative left ventricular support in a patient with c...
21453929 - Influence of time-varying mean heart rate in coronary artery disease diagnostic perform...
21526049 - Percutaneous approach to treatment of coronary disease in a patient with uremic cardiom...
21331619 - Long-term results of the maze procedure on left ventricular function for persistent atr...
21323409 - The development of door-to-angiography time in the last 14 years for patients with acut...
24411099 - On the geometrical relationship between global longitudinal strain and ejection fractio...
11445249 - Met-enkephalin levels during ptca-induced myocardial ischemia.
1109319 - Return of normal conduction after paroxysmal heart block. report of a case with major d...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-31
Journal Detail:
Title:  Journal of interventional cardiology     Volume:  -     ISSN:  1540-8183     ISO Abbreviation:  J Interv Cardiol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907826     Medline TA:  J Interv Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013, Wiley Periodicals, Inc.
Guthrie Clinic, Sayre, Pennsylvania.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Identification of differentially expressed proteins of Arthrospira (Spirulina) plantensis-YZ under s...
Next Document:  Substrate-Initiated Synthesis of Cell-Penetrating Poly(disulfide)s.